Tag: USA

U.S. administers over 419 million doses of COVID-19 vaccines – CDC

FILE PHOTO: A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell(Reuters) – The United States has administered 419,020,753 doses of COVID-19 vaccines in the country as of Friday morning and distributed 514,925,015 doses, the U.S. Centers for Disease Control and Prevention said.

Pfizer, BioNTech ask U.S. regulators to OK COVID-19 vaccine for kids

FILE PHOTO: Syringes filled with a doses of Pfizer’s coronavirus disease (COVID-19) vaccine are seen at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021. REUTERS/Brendan McDermidWASHINGTON (Reuters) – Pfizer Inc and BioNTech have asked U.S. regulators to approve emergency use of their COVID-19

U.S. administers 390.7 million doses of COVID-19 vaccines – CDC

FILE PHOTO: A large vaccination site is shown as people with preexisting health conditions are granted access to a vaccination during the outbreak of the coronavirus disease (COVID-19) in Inglewood, California, U.S., March 15, 2021. REUTERS/Mike Blake(Reuters) – The United States has administered 390,664,923 doses of COVID-19 vaccines in the country as of Monday morning

Moderna to join S&P 500, shares jump after hours

Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration(Reuters) – Moderna Inc will join the S&P 500 index as of the start of trading on July 21, replacing Alexion Pharmaceuticals, S&P Dow Jones Indices said in a statement on Thursday. Moderna shares rose 6%

CDC says U.S. young adults less likely to take COVID-19 vaccine

FILE PHOTO: Max Dobles, 17, who has Crohn’s disease, looks at Dr. Mayank Amin before receiving the Pfizer-BioNTech vaccine against the coronavirus disease (COVID-19) at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., March 3, 2021. REUTERS/Hannah Beier(Reuters) – Younger adults are seeking out COVID-19 vaccines at a slower rate than older adults, and if that pace